Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Oct;29(5):239-46.
doi: 10.1111/phpp.12061.

BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)

Affiliations
Randomized Controlled Trial

BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)

Medhat El-Mofty et al. Photodermatol Photoimmunol Photomed. 2013 Oct.

Abstract

Background: Vitiligo is an acquired pigmentary disorder that affects between 1% and 2% of the general population. Phototherapy remains the cornerstone of treatment, with NB-UVB being the most frequently used. BB-UVA can be a plausible alternative for darker population; skin photo type III and IV.

Patients and methods: The study was a prospective, randomized, controlled, and single-blinded clinical trial, conducted on 40 patients with bilateral symmetrical vitiligo. The patients were randomly divided into two equal groups; group (A) received a fixed dose of 15 J/cm(2) BB-UVA, while group (B) received NB-UVB. The study was conducted for a period of 16 weeks (48 sessions).

Results: The final percentage of clinical improvement was significantly higher (P = 0.047) within the BB-UVA group (63.82% ± 27.42), than within the NB-UVB group (44.32% ± 29.78).

Conclusion: BB-UVA can be considered as an alternative treatment line for vitiligo.

Keywords: BB-UVA; NB-UVA; vitiligo.

PubMed Disclaimer

Publication types

LinkOut - more resources